Browsing by Author Wang, Xiaopei

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 34  next >
Issue DateTitleAuthor(s)
Dec-2021Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in ChinaZhang, Chen; Mi, Lan; Wu, Meng; Liu, Weiping; Ma, Hongmei; Ren, Jianxin; Zhao, Linjun; Wang, Xiaopei; Song, Yuqin; Zhu, Jun
Dec-2022Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in ChinaLiu, Weiping; Ji, Jie; Zou, Dehui; Cao, Yang; Xu, Yajing; Zhou, Jian; Gao, Sujun; Wang, Fengrong; Chen, Wenming; Du, Juan; Zhou, Hui; Zhou, Fuling; Shi, Jimin; Zhang, Xi; Yang, Jianmin; Jing, Hongmei; Jiang, Zhongxing; Liu, Hui; Li, Caixia; Peng, Hongling; Jiang, Songfu; Wei, Xiaolei; He, Pengcheng; Liu, Yao; Yang, Haiyan; Li, Zengjun; Huang, Xiaobing; Liu, Lin; Shen, Lijing; Liu, Chuanfang; Song, Yuqin; Qiu, Lugui; Wang, Xiaopei; Ma, Jun; Zhu, Jun
15-Apr-2022Burden of lymohoma in China, 1990-2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019Liu, Weiping; Liu, Jiangmei; Song, Yuqin; Wang, Xiaopei; Mi, Lan; Cai, Cai; Zhao, Donglu; Wang, Lijun; Ma, Jun; Zhu, Jun
2018CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin LymphomaYing, Zhitao; Wang, Wen; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Hao, Ming; Yang, Su; Zhou, Yan; Li, James; Song, Yuqin; Zhu, Jun
Jul-2020Chemotherapy with a Pegylated Liposomal Doxorubicin-Containing Regimen in Newly Diagnosed Hodgkin Lymphoma PatientsLiu, Weiping; Yang, Mingzi; Ping, Lingyan; Xie, Yan; Wang, Xiaopei; Zhu, Jun; Song, Yuqin
2017Chimeric antigen receptor-modified T cells directed against CD19 in patients with relapsed or refractory CD19-positive B-cell lymphomas: interim analysis of a phase 1 studyYing, Zhitao; Xiang, Xiaoyu; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Liu, Yanling; Yue, Yunqiang; Yu, Xueyun; Liu, Hanzhi; Duan, Panpan; Mamuti, Mierzhati; Guo, Xiaokai; Chen, Feng; Wu, Xiaoyan; Zhang, Junqing; Zhang, Tingting; Huang, Xue F.; Jones, Lindsey; Kang, Xi; Chen, Si-Yi; Zhu, Jun
2016Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndromeJia, Jing; Song, Yuqin; Lin, Ningjing; Liu, Weiping; Ping, Lingyan; Zheng, Wen; Wang, Xiaopei; Xie, Yan; Tu, Meifeng; Zhang, Chen; Ying, Zhitao; Deng, Lijuan; Ding, Ning; Zhu, Jun
31-Dec-2022Clinical prognostic risk analysis and progression factor exploration of primary breast lymphomaDeng, Jili; Mi, Lan; Wang, Xiaopei; Zhu, Jun; Zhang, Chen; Song, Yuqin
15-Apr-2021Conditional survival and hazards of death for peripheral T-cell lymphomasGao, Hongye; Ji, Xinqiang; Liu, Xin; Mi, Lan; Liu, Weiping; Wang, Xiaopei; Zhu, Jun; Song, Yuqin
25-Feb-2021Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignanciesYing, Zhitao; He, Ting; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Wu, Meng; Feng, Feier; Leng, Xin; Du, Tingting; Qi, Feifei; Hu, Xuelian; Ding, Yanping; Lu, Xin-an; Song, Yuqin; Zhu, Jun
Dec-2022Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trialYing, Zhitao; Xie, Yan; Zheng, Wen; Liu, Weiping; Lin, Ningjing; Tu, Meifeng; Wang, Xiaopei; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Wu, Meng; Feng, Feier; Du, Tingting; Tang, Yongjing; Su, Fang; Guo, Ziyu; Li, James; Song, Yuqin; Zhu, Jun
2015Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven originDeng, Lijuan; Song, Yuqin; Young, Ken H.; Hu, Shimin; Ding, Ning; Song, Weiwei; Li, Xianghong; Shi, Yunfei; Huang, Huiying; Liu, Weiping; Zheng, Wen; Wang, Xiaopei; Xie, Yan; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Sun, Yingli; Zhu, Jun
Mar-2020High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from ChinaXie, Yan; Wang, Xiaopei; Leng, Xin; Zheng, Wen; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Wu, Meng; Song, Yuqin; Zhu, Ju
2018Incidence, Clinical Characteristics and Outcome of Cardiac Toxicity in Elderly Patients with Diffuse Large B-Cell LymphomaLiu, Wei Ping; Xu, Yan Feng; Xie, Yan; Wang, Xiaopei; Song, Yuqin; Zhu, Jun
2007Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanomaGuo, Jun; Zhu, Jun; Sheng, Xinan; Wang, Xiaopei; Qu, Li; Han, Yan; Liu, Yuexiang; Zhang, Hui; Huo, Ling; Zhang, Shuhui; Lin, Baohe; Yang, Zhi
2019ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphomaLiu, Yalu; Wang, Xiaogan; Deng, Lijuan; Ping, Lingyan; Shi, Yunfei; Zheng, Wen; Lin, Ningjing; Wang, Xiaopei; Tu, Meifeng; Xie, Yan; Liu, Weiping; Ying, Zhitao; Zhang, Chen; Pan, Zhengying; Wang, Xi; Ding, Ning; Song, Yuqin; Zhu, Jun
2009L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal typeYong, Weiben; Zheng, Wen; Zhu, Jun; Zhang, Yuntao; Wang, Xiaopei; Xie, Yan; Lin, Ningjing; Xu, Bo; Lu, Aiping; Li, Jiyou
2019Mortality of lymphoma and myeloma in China, 2004-2017: an observational studyLiu, Weiping; Liu, Jiangmei; Song, Yuqin; Wang, Xiaopei; Zhou, Maigeng; Wang, Lijun; Ma, Jun; Zhu, Jun
2015Outcomes of dose-adjusted Berlin-Frankfurt-Munster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphomaXie, Yan; Zhang, Yuntao; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Song, Yuqin; Zhu, Jun
2018PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivityZheng, Wen; Gao, Yuhuan; Ke, Xiaoyan; Zhang, Weijing; Su, Liping; Ren, Hanyun; Lin, Ningjing; Xie, Yan; Tu, Meifeng; Liu, Weiping; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Deng, Lijuan; Wang, Xiaopei; Song, Yuqin; Zhu, Jun